Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin and Ibuprofen for CSF Beta-Amyloid
NCT00046358Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lovastatin, ibuprofen in Alzheimer's disease (AD), sponsored by National Institute of Mental Health. Started Sep 2002; status: completed.
02
Drugs
lovastatinibuprofen
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00046358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046358.